Last updated on March 2019

Study of the Cutera Enlighten Device for the Treatment of Melasma and Facial Inflammatory Pigmentation


Brief description of study

This is single-center, open-label, prospective study of the Cutera Enlighten device to assess the efficacy and safety of this device in treating melasma (which is skin discoloration appearing on the face due to exposure to the sun) and facial inflammatory pigmentation (which can occur due to injury or inflammation).

All enrolled subjects will receive up to three Cutera Enlighten laser treatments, spaced one month apart, followed by 4 week and 12 week follow-up visits after their last treatment. This means there are a minimum of 3 office visits and a maximum of 5, with the addition of an initial screening visit, all of which include photos being taken in order to track treatment process. All services are provided at no cost.

 

Clinical Study Identifier: TX216163

Contact Investigators or Research Sites near you

Start Over

Taylor Hardy

Sadick Research Group
New York, NY United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.